PlainPharmaWatch

CMS Open Payments · Tool

Dermavant Sciences, Inc. vs Route 92 Medical, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Route 92 Medical, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,140, versus 71 for the other company. Its single largest recorded recipient represents 0.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Dermavant Sciences, Inc.
HHI 71 · top recipient 0.0%
Ranked #1,733 of 1,838 companies by HHI
Route 92 Medical, Inc.
HHI 2,140 · top recipient 0.4%
Ranked #727 of 1,838 companies by HHI

Payment Overview

Total Payments
$9.7M
% of Industry
0.1%
Transactions
89,827
Avg per Transaction
$107.84
Recipients
73,486
Avg per Recipient
$131.82
Payment Types
6
Top Payment Type
Compensation for Services Other Than Consulting
Total Payments
$9.7M
% of Industry
0.1%
Transactions
812
Avg per Transaction
$11.9K
Recipients
774
Avg per Recipient
$12.5K
Payment Types
4
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Dermavant Sciences, Inc. vs Route 92 Medical, Inc. - total reported payments in CMS Open Payments PY2024

Dermavant Sciences, Inc.$9.7MRoute 92 Medical, Inc.$9.7M

Payment Types Breakdown

Dermavant Sciences, Inc.

Compensation for Services Other Than Consulting $2.4M

24.5%

Consulting Fee $2.2M

23.0%

Food and Beverage $1.5M

15.7%

Travel and Lodging $377.1K

3.9%

Grant $151.1K

1.6%

Education $3.6K

0.0%

Route 92 Medical, Inc.

Consulting Fee $644.6K

6.7%

Food and Beverage $38.9K

0.4%

Travel and Lodging $21.0K

0.2%

Entertainment $245.02

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Dermavant Sciences, Inc.

  1. 1

    NATIONAL JEWISH HEALTH

    $323,050.00 · 4 txns

  2. 2

    GEORGE LEWITT

    $123,192.80 · 97 txns

  3. 3

    ALEXANDRA GOLANT

    $113,487.41 · 94 txns

  4. 4

    NAIEM ISSA

    $100,248.14 · 131 txns

  5. 5

    CORY RUBIN

    $90,403.84 · 52 txns

Route 92 Medical, Inc.

  1. 1

    FABIO SETTECASE

    $264,725.47 · 14 txns

  2. 2

    WARREN KIM

    $116,252.40 · 27 txns

  3. 3

    MATTHEW ALEXANDER

    $110,061.51 · 15 txns

  4. 4

    JOEY ENGLISH

    $98,269.62 · 40 txns

  5. 5

    AJIT PURI

    $15,330.11 · 9 txns

Summary Comparison

Metric Dermavant Sciences, Inc. Route 92 Medical, Inc.
Total Payments $9.7M $9.7M
% of Industry Total 0.1% 0.1%
Transaction Count 89,827 812
Avg per Transaction $107.84 $11.9K
Recipient Count 73,486 774
Avg per Recipient $131.82 $12.5K
Payment Type Count 6 4
Top Payment Type Compensation for Services Other Than Consulting Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.